HYPERA S.A.

Publicly-Held Company

Corporate Taxpayer ID CNPJ/MF No. 02.932.074/0001-91

Company Registry (NIRE) 35.300.353.251

CVM Code No. 21431

NOTICE TO THE MARKET

HYPERA S.A. ("Company" or "Hypera Pharma") hereby informs that, pursuant to the provisions of article 12 of CVM Instruction 358/02, has received a notice from BlackRock, Inc. ("BlackRock") regarding the reduction of equity interests in the Company. BlackRock informed that manages 31,607,122 (thirty one million, six hundred and seven thousand, one hundred and twenty two) common shares of the Company, corresponding to approximately 4.99% of its capital stock.

Additionally, we inform that, according to the same notice, BlackRock and its affiliates currently do not intend to change the control or the management structure of the Company.

Enclosed herewith is the letter sent by BlackRock.

São Paulo, August 8th, 2019.

HYPERA S.A.

Adalmario Ghovatto Satheler do Couto

Investor Relations Officer

Attachments

  • Original document
  • Permalink

Disclaimer

Hypera SA published this content on 08 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2019 22:25:01 UTC